isoleucine has been researched along with oxyntomodulin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallwitz, B; Schmidt, WE | 1 |
| Abbott, CA; Demuth, HU; Geier, MS; Howarth, GS; Yazbeck, R | 1 |
1 review(s) available for isoleucine and oxyntomodulin
| Article | Year |
|---|---|
Dipeptidyl peptidases and inflammatory bowel disease.
Topics: Animals; Colitis; Dextran Sulfate; Dipeptidyl Peptidase 4; Disease Models, Animal; Glucagon-Like Peptide 2; Glucagon-Like Peptides; Humans; Indicators and Reagents; Inflammatory Bowel Diseases; Intestinal Mucosa; Intestines; Isoleucine; Mice; Mice, Knockout; Peptide Fragments; Serine Proteinase Inhibitors | 2006 |
1 other study(ies) available for isoleucine and oxyntomodulin
| Article | Year |
|---|---|
[Inhibition of incretin degradation--a new therapy principle for treatment of type 2 diabetes?].
Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Hypoglycemic Agents; Isoleucine; Peptide Fragments; Rats; Rats, Zucker; Thiazoles | 1999 |